...
首页> 外文期刊>Hepato-gastroenterology. >Clinical features and management of duodenal fistula in patients with Crohn's disease
【24h】

Clinical features and management of duodenal fistula in patients with Crohn's disease

机译:克罗恩病患者十二指肠瘘的临床特征和处理

获取原文
获取原文并翻译 | 示例

摘要

Background/Aims: Duodenal fistula is rare in patients with Crohn's disease and almost all patients require surgery. Generally surgery for duodenal CD and reconstruction is considered difficult. We reviewed the clinical features of duodenal fistula with CD and considered suitable preoperative treatments. Methodology: We reviewed the records of 10 patients with duodenal fistula complicating CD between September 1974 and April 2009. Results: Mean age at surgery was 31.5 years (range 22-36). Mean duration from onset of CD or previous surgery was 49.8 months (range 1.5-172.6). All patients were treated with total parenteral nutrition before surgery, 3 patients with steroids and 1 patient with infliximab. Synergistic effects of these immunomodulators were not examined in this study. Although preoperative treatments improved the values of CD activity index (p<0.01) all patients required surgical treatment. Duodenal fistula in all patients resulted from intrinsic CD lesion at the colon or ileum. Although immunmodulators had no additional effects on shortening hospital stay or improving activity index, simple fistula repair was performed in all patients. Conclusions: Although the additional effects of immunomodulators were not confirmed, the sufficient preoperative treatment for duodenal fistula with CD to reduce disease activity seems likely to facilitate subsequent minimal surgery.
机译:背景/目的:克罗恩病患者很少见十二指肠瘘,几乎所有患者都需要手术。通常认为十二指肠CD和重建手术很困难。我们回顾了CD十二指肠瘘的临床特征,并考虑了合适的术前治疗方法。方法:我们回顾了1974年9月至2009年4月间10例十二指肠瘘并发CD的患者的记录。结果:手术的平均年龄为31.5岁(范围22-36)。从CD发作或以前的手术开始的平均持续时间为49.8个月(范围1.5-172.6)。所有患者在手术前均接受了全胃肠外营养治疗,其中3例接受类固醇治疗,1例接受英夫利昔单抗治疗。在这项研究中未检查这些免疫调节剂的协同作用。尽管术前治疗改善了CD活性指数(p <0.01)的值,但所有患者均需要手术治疗。所有患者的十二指肠瘘是结肠或回肠固有的CD病变所致。尽管免疫调节剂对缩短住院时间或改善活动指数没有其他影响,但所有患者均进行了简单的瘘管修复。结论:尽管尚未确认免疫调节剂的其他作用,但对CD进行十二指肠瘘术前充分治疗以降低疾病活动性似乎足以促进随后的最低限度手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号